Peter Attia· MD
we should be selecting people also based on causes i can measure your apo b pretty precisely i could measure your non-hdl cholesterol a little less precisely but pretty well
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
we should be selecting people also based on causes i can measure your apo b pretty precisely i could measure your non-hdl cholesterol a little less precisely but pretty well
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
the way we can deal with this and what we've done is develop what's called the causal benefit model is we measure non-hdl or apob and and we can project the risk over 20 or 30 years